CCL26



CCL26

T1TT1R2RR2G3GG3S4SS4D5DD5I6II6S7SS7K8KK8T9TT9C10CC10C11CC11F12FF12Q13QQ13Y14YY14S15SS15H16HH16K17KK17P18PP18L19LL19P20PP20W21WW21T22TT22W23WW23V24VV24R25RR25S26SS26Y27YY27E28EE28F29FF29T30TT30S31SS31N32NN32S33SS33C34CC34S35SS35Q36QQ36R37RR37A38AA38V39VV39I40II40F41FF41T42TT42T43TT43K44KK44R45RR45G46GG46K47KK47... and 24 more residue(s)...... and 24 more residue(s)

SMILES None
InChIKey None
Sequence TRGSDISKTCCFQYSHKPLPWTWVRSYEFTSNSCSQRAVIFTTKRGKKVCTHPRKKWVQKYISLLKTPKQL

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections



No bioactivity data available.

CCL26

T1TT1R2RR2G3GG3S4SS4D5DD5I6II6S7SS7K8KK8T9TT9C10CC10C11CC11F12FF12Q13QQ13Y14YY14S15SS15H16HH16K17KK17P18PP18L19LL19P20PP20W21WW21T22TT22W23WW23V24VV24R25RR25S26SS26Y27YY27E28EE28F29FF29T30TT30S31SS31N32NN32S33SS33C34CC34S35SS35Q36QQ36R37RR37A38AA38V39VV39I40II40F41FF41T42TT42T43TT43K44KK44R45RR45G46GG46K47KK47... and 24 more residue(s)...... and 24 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.